Thornton Peter J. 4
4 · AVADEL PHARMACEUTICALS PLC · Filed Aug 9, 2019
Insider Transaction Report
Form 4
Thornton Peter J.
Director
Transactions
- Award
Stock Option (right to buy)
2019-08-07+60,000→ 60,000 totalExercise: $2.03Exp: 2029-08-07→ ADSs (60,000 underlying)
Holdings
- 33,055
ADSs
- 35,000
Stock Option (right to buy)
Exercise: $10.51From: 2018-06-28Exp: 2022-06-28→ ADSs (35,000 underlying)
Footnotes (4)
- [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- [F2]Includes 27,900 restricted ADSs granted under the issuer's Omnibus Incentive Compensation Plan on 08/01/2018; one-third (1/3) of the ADSs will vest on each of the first three anniversaries of the grant date.
- [F3]Options become exercisable as to all 35,000 ADSs on the first anniversary of the 06/28/2017 grant date.
- [F4]Options become exercisable as to 20,000 ADSs on each of the first three anniversaries after the 08/07/2019 grant date.